n/a
Article Publish Status: FREE
Abstract Title:

Triggers Apoptosis, Combats Oxidative Stress and Inhibits Growth of Ehrlich Ascites Carcinoma Mouse Model.

Abstract Source:

Iran J Pharm Res. 2018 ;17(4):1328-1338. PMID: 30568691

Abstract Author(s):

Nada H Eisa, Heba S Said, Nehal M ElSherbiny, Laila A Eissa, Mamdouh M El-Shishtawy

Article Affiliation:

Nada H Eisa

Abstract:

The aim of this study is to investigate the antitumor activity and possible molecular mechanism of() against Ehrlich ascites carcinomaand., ascetic fluid volume, body weight, serum malondialdehyde (MDA) level and total antioxidant capacity (TAC) were determined using Ehrlich ascites carcinoma (EAC) bearing mice.MTT assay was used. RT-PCR was used to investigate role ofin apoptosis by analyzing the expression of Bax, caspase-9, and Bcl-2 genes. The effect ofon caspase-9 enzyme activity was also tested.and/or Doxorubicin (Dox) treatment significantly suppressed EAC growth as compared to EAC/oil control mice.treatment showed a dose-dependent inhibition of EAC cells as indicated by MTT assay. We found that significant increase in MDA level and decrease in TAC caused by Dox treatment were significantly reduced by combination withtreatment. Bax, caspase-9 genes' expression and caspase-9 enzymatic activity were significantly increased, while Bcl-2 gene expression was significantly decreased intreated mice.may act as a promising anticancer agent either alone or more effectively in combination with Dox through apoptotic cell death induction.

Study Type : Animal Study, In Vitro Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.